| Literature DB >> 26540494 |
Eva Rivero-Buceta1, Paula Carrero2, Elena Casanova3, Elisa G Doyagüez4, Andrés Madrona1, Ernesto Quesada1, María Jesús Peréz-Pérez1, Raquel Mateos5, Laura Bravo5, Leen Mathys6, Sam Noppen6, Evgeny Kiselev7, Christophe Marchand7, Yves Pommier7, Sandra Liekens6, Jan Balzarini6, María José Camarasa1, Ana San-Félix8.
Abstract
The glycoprotein gp120 of the HIV-1 viral envelope has a high content in mannose residues, particularly α-1,2-mannose oligomers. Compounds that interact with these high-mannose type glycans may disturb the interaction between gp120 and its (co)receptors and are considered potential anti-HIV agents. Previously, we demonstrated that a tripodal receptor (1), with a central scaffold of 1,3,5-triethylbenzene substituted with three 2,3,4-trihydroxybenzoyl groups, selectively recognizes α-1,2-mannose polysaccharides. Here we present additional studies to determine the anti-HIV-1 activity and the mechanism of antiviral activity of this compound. Our studies indicate that 1 shows anti-HIV-1 activity in the low micromolar range and has pronounced gp120 binding and HIV-1 integrase inhibitory capacity. However, gp120 binding rather than integrase inhibition seems to be the primary mechanism of antiviral activity of 1.Entities:
Keywords: AIDS; Antiviral agents; HIV; Integrase; Polyphenols
Mesh:
Substances:
Year: 2015 PMID: 26540494 PMCID: PMC7750885 DOI: 10.1016/j.ejmech.2015.10.027
Source DB: PubMed Journal: Eur J Med Chem ISSN: 0223-5234 Impact factor: 6.514